Category: National Politics

  • Dave McCormick joins fellow Senate Republicans urging RFK Jr. to rescind approval for an abortion pill

    Dave McCormick joins fellow Senate Republicans urging RFK Jr. to rescind approval for an abortion pill

    U.S. Sen. Dave McCormick (R., Pa.) has joined fellow Senate Republicans in signing on to a letter urging top health officials in the Trump administration to rescind approval for a drug used in one of the most common methods of abortion.

    In a letter to Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary earlier this month, the Republican senators recommended, among other things, that officials re-evaluate the safety of mifepristone, one of two pills commonly used in a medication abortion, and suspend the distribution of the drug and its generic versions, saying it should be considered an “imminent hazard” at the federal level.

    “Today, your agencies have all the information they need to bring an end to previous Democrat administrations’ abortion drug regulations while a comprehensive review is conducted,” the Republicans wrote in the letter.

    Only two Senate Republicans, Lisa Murkowski (R., Alaska) and Susan Collins (R., Maine), did not sign the letter.

    Mifepristone is considered safe and effective and is used to terminate early-stage pregnancies and manage miscarriages, according to the American Medical Association. It received initial approval from the Food and Drug Administration in September 2000.

    McCormick’s signature on the letter could signal a change in how the Pennsylvania Republican views abortion regulation. During his campaign last fall, McCormick said during a debate that he wants to leave regulation to individual states, which has been the status quo since the U.S. Supreme Court overturned Roe v. Wade in 2022. His backing of the letter, which encourages sweeping policy decisions at the national level, suggests otherwise.

    “Sen. McCormick has concerns about the adverse effects mifepristone can have on women, as shown in a recent study,” a spokesperson for McCormick said in a statement Friday evening. “This letter addresses those potential impacts on women’s health and encourages HHS and FDA to reevaluate the potential risks and harms associated with mifepristone. Sen. McCormick also issued a statement yesterday applauding the White House’s efforts to lower IVF costs.”

    Eugene DePasquale, chair of the Pennsylvania Democratic Party, accused him of betraying his constituents.

    “Sen. McCormick’s support for an extreme anti-choice policy that could threaten the lives of Pennsylvania women is a shameful betrayal of his constituents,” DePasquale said. “This type of extreme policy coming out of Washington only makes it clearer that everything is on the line when it comes to protecting our freedom — and it is up to us to do it right here at the state level.”

    Last month, Kennedy said the FDA is reviewing the safety of mifepristone.

    “By law, the FDA has very limited discretion in deciding whether to approve a generic drug, and the FDA’s approval of a generic mifepristone is not an endorsement of the product. HHS remains committed to its study of the reported adverse effects of mifepristone,” White House spokesperson Kush Desai said in a statement to The Inquirer.

    Medical abortions, where mifepristone is used as part of a two-drug regimen along with misoprostol, account for more than half of all abortions performed in the U.S., according to the Cleveland Clinic in 2024.

    Should the FDA revoke its approval of mifepristone, medical abortions won’t be eradicated. Medication abortions are possible using just misoprostol, but the method is less effective, according to a 2021 report from the American Family Physician.

    In addition to their safety concerns, Senate Republicans are also urging Kennedy and Makary to suspend approving new generic versions of mifepristone awaiting the results of a safety review of the Risk Evaluation and Mitigation Strategies (REMS) for the drug. REMS are safety programs for certain medications as required by the FDA.

    The Republicans are also urging the federal government to require mifepristone and its generic versions to be distributed in person, not through mail, and not at a pharmacy.

    The letter also claims that the U.S. has an “‘abortion-on-demand’ culture,” referring to the accessibility of mifepristone through mail. But, according to Planned Parenthood, a telehealth call is required before any pill is shipped.

    Staff writer Katie Bernard contributed to this article.

    This story was updated to include a comment from Sen. McCormick.

  • Barack Obama endorses Mikie Sherrill for New Jersey governor

    Barack Obama endorses Mikie Sherrill for New Jersey governor

    Former President Barack Obama endorsed U.S. Rep. Mikie Sherrill, the Democratic nominee for New Jersey governor, who is locked in a tight race with Republican Jack Ciattarelli.

    Obama’s announcement just weeks ahead of the Nov. 4 election came in the form of an ad paid for by Sherrill’s campaign that Sherrill shared on X Friday morning.

    “Mikie is a mom who will drive down costs for New Jersey families,” Obama said in the ad, echoing her campaign’s core message. “As a federal prosecutor and former Navy helicopter pilot, she worked to keep our communities safe.”

    “Mikie’s integrity, grit, and commitment to service are what we need right now in our leaders,” he adds.

    Sherrill maintains a single-digit lead in polls over Ciattarelli, a former Assembly member who also ran for governor in 2017 and 2021 and has the endorsement of President Donald Trump.

    In a statement, Sherrill praised Obama for leading “historic efforts to lower healthcare costs” and criticized Ciattarelli for defending cuts to Medicaid in Trump’s “big beautiful bill.”

    “There’s so much at stake in this election, so President Obama and I are mobilizing New Jerseyans to make a plan to vote on or before November 4,” Sherrill added.

    The race has been tightening, with each candidate solidifying their bases.

    New Jersey is only one of two states with a race for governor this year, along with Virginia, and national money has been flowing into the race.

    Sherrill last week appeared in South Jersey last week with Sens. Cory Booker (D., N.J.) and Amy Klobuchar (D., Minn.) and in her hometown of Montclair with former U.S. Rep. Gabby Giffords, an Arizona Democrat. She will appear in this weekend with Maryland Gov. Wes Moore.

    Ciattarelli appeared on Wednesday with Ohio gubernatorial candidate Vivek Ramaswamy, who co-founded Trump’s DOGE and who appeared at a GOP summit in Atlantic City earlier this year to garner enthusiasm ahead of the gubernatorial primary.

    Trump does not currently have plans to appear in the state with Ciattarelli, Axios reported. While New Jersey shifted more in support of Trump in 2024 he still lost the state by 6 percentage points.

    The president held a tele-rally ahead of the primary after Ciattarelli pocketed his endorsement in May. Trump is planning to host more of these, Axios reported.

    An earlier version of this story misidentified Vivek Ramaswamy’s position. He is a candidate for Ohio governor.

  • State Sen. Sharif Street has early fundraising lead in Philly congressional race, but his competitors are close behind

    State Sen. Sharif Street has early fundraising lead in Philly congressional race, but his competitors are close behind

    State Sen. Sharif Street has an early fundraising lead over his competitors in next year’s Democratic primary for a storied Philadelphia congressional seat, according to new campaign finance reports.

    But the race is in its early stages, and candidates who entered the race after Street still have plenty of time to catch up before the May 2026 primary.

    Street, the son of former Mayor John F. Street, entered the race for Pennsylvania’s 3rd Congressional District in early July, days after U.S. Rep. Dwight Evans (D., Philadelphia) announced he would not seek reelection. Street’s campaign launch coincided with the beginning of the campaign finance reporting period, allowing him three full months to solicit contributions and seek endorsements.

    He took in about $352,000 from July 1 through Sept. 30, according to the Federal Election Commission. His campaign spent $33,000 during that time, and he finished the period with $372,000 in cash on hand, which is also the most of any candidate in the race. (Street’s cash reserves are higher than his fundraising because he carried over money from a previous campaign account.)

    “Our strong fundraising results put us in a commanding position,” Street campaign manager Josh Uretsky said in a statement. “We’re building a strong campaign that will hit every neighborhood in the Third District by leveraging our broad-based coalition.”

    window.addEventListener(“message”,function(a){if(void 0!==a.data[“datawrapper-height”]){var e=document.querySelectorAll(“iframe”);for(var t in a.data[“datawrapper-height”])for(var r,i=0;r=e[i];i++)if(r.contentWindow===a.source){var d=a.data[“datawrapper-height”][t]+”px”;r.style.height=d}}});

    State Rep. Chris Rabb, an anti-establishment progressive, who raised $257,000, also announced his campaign in July.

    Rabb’s haul was notable for a candidate with little support among Philadelphia’s established political organizations, such as the deep-pocketed building trades unions that endorsed Street this week. As he has in past runs, Rabb said he is eschewing contributions from corporate-backed political action committees, and tapping into a national network of progressive small-dollar donors.

    “This is a robust, grassroots campaign that’s fueled and funded by a growing movement of Philadelphians and citizens far & wide who want a bold, independent-minded and accountable Democrat to represent the bluest congressional district in the nation,” Rabb said in a statement.

    His campaign spent $76,000, and carried forward $181,000.

    State Rep. Morgan Cephas, a West Philly Democrat who chairs the Philadelphia delegation to the state House, collected $156,000 in contributions, a respectable sum given that she entered the race about a month before the reporting deadline. Her campaign spent $37,000 and had $119,000 in cash.

    In a statement, Cephas said “the excitement about our campaign is palpable.”

    “I understand the problems of Philadelphia because I’ve lived them for the last 41 years,” Cephas said. “Together we can deliver real results for our community.”

    Political outsiders aim to shake up race

    David Oxman, a physician who lives in South Philadelphia, brought in $107,000, spent $35,000, and had a healthy $332,000 in the bank.

    “Since day one, this campaign has been fueled by healthcare professionals, small business owners, and working families across Philadelphia who are ready to take power back from leaders bought by corporate interests,” Oxman said in a statement.

    David Oxman, an intensive care doctor and medical school professor at Thomas Jefferson University Hospital, is running for Congress. Oxman, 58, of Bella Vista, joins a race that includes State Reps. Sharif Street and Chris Rabb to replace retiring U.S. Rep. Dwight Evans.

    The campaign for Temple University professor Karl Morris raised $28,000, spent $26,000, and had $12,000 in cash on hand.

    “As a scientist, teacher, and a non-politician running an outsider campaign, my focus is on connecting with everyday Philadelphians,” Morris, a computer scientist, said in a statement. “Career politicians and the donor class want politics as usual. I’m prepared to make sure everyone in Philadelphia receives equal benefits and equal protections.”

    One notable candidate, physician Ala Stanford, entered the race after the close of the reporting period and has not yet submitted a campaign finance filing. Stanford was a founder of the Black Doctors COVID-19 Consortium and has been endorsed by Evans.

    “In just a few weeks in the race, Dr. Stanford has generated significant momentum — in contributions, volunteer engagement, and community enthusiasm,” Stanford campaign manager Aaron Carr said in a statement.

    Pennsylvania’s 3rd Congressional District, which includes parts of North, Northwest, West, and South Philadelphia, is one of the most Democratic seats in the nation. With Evans retiring from the seat he has held for nearly a decade, the field could still be in flux as more Philly politicians eye the potentially once-in-a-generation ticket to Washington.

    Map of Pennsylvania’s Third Congressional District.

    While the race remains competitive, Street’s early fundraising lead will help cement his status as the favorite of the local political establishment. Democratic City Committee chair Bob Brady said this week that party ward leaders will likely vote to endorse Street after this year’s election cycle wraps up next month.

    “We’re fully prepared to take advantage of this early lead,” Uretsky said.

    Brian Fitzpatrick outraises competitors in Bucks County congressional race

    In Pennsylvania’s 1st Congressional District, where Democrats have made ousting Republican U.S. Rep. Brian Fitzpatrick a top priority, the incumbent outraised his leading Democratic challenger by a nearly 4-1 ratio, bringing in $886,049 this quarter.

    Rep. Brian Fitzpatrick (R., Bucks and Montgomery) speaks during the opening session of the National Treasury Employees Union (NTEU) Legislative Conference in Washington in March.

    Unlike the deep-blue 3rd District, the fate of the 1st District will likely be decided in next year’s general election, and not the primary. The district, which includes all of Bucks County and a part of Montgomery County, is the only Philadelphia-area congressional seat represented by a Republican.

    Democratic County Commissioner Bob Harvie announced plans to challenge Fitzpatrick earlier this year.

    Harvie, viewed as the favorite to win the Democratic nomination, raised $217,745 last quarter. The other Democrat in the race, attorney Tracy Hunt, raised $36,692.

    This suburban content is produced with support from the Leslie Miller and Richard Worley Foundation and The Lenfest Institute for Journalism. Editorial content is created independently of the project donors. Gifts to support The Inquirer’s high-impact journalism can be made at inquirer.com/donate. A list of Lenfest Institute donors can be found at lenfestinstitute.org/supporters.